- Home
- Publications
- Publication Search
- Publication Details
Title
Mycobacterium bovis BCG in metastatic melanoma therapy
Authors
Keywords
-
Journal
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
Volume 103, Issue 19, Pages 7903-7916
Publisher
Springer Science and Business Media LLC
Online
2019-08-12
DOI
10.1007/s00253-019-10057-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012
- (2018) Melina Arnold et al. INTERNATIONAL JOURNAL OF CANCER
- Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study
- (2018) Margaret K. Callahan et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy
- (2018) Michael Lattanzi et al. JNCI-Journal of the National Cancer Institute
- Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses
- (2018) Wei Luo et al. VACCINE
- Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
- (2018) Gianfranco Mattia et al. Cell Death & Disease
- Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy
- (2018) Michael Lattanzi et al. JNCI-Journal of the National Cancer Institute
- An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
- (2018) Ryan J. Sullivan et al. Journal for ImmunoTherapy of Cancer
- Melanoma Immunotherapy: Next-Generation Biomarkers
- (2018) Sabrina A. Hogan et al. Frontiers in Oncology
- The age of enlightenment in melanoma immunotherapy
- (2018) Mark R. Albertini Journal for ImmunoTherapy of Cancer
- Advanced stage melanoma therapies: Detailing the present and exploring the future
- (2018) Chelsea Luther et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants
- (2018) María B. Pampena et al. Frontiers in Immunology
- Immunotherapy for the Treatment of Urothelial Carcinoma
- (2017) Nicholas M. Donin et al. JOURNAL OF UROLOGY
- Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin
- (2017) Caroline Rizzi et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Treatment of advanced melanoma - A changing landscape
- (2017) Adriana Hepner et al. Revista da Associacao Medica Brasileira
- Recombinant Bacille Calmette-Guérin coexpressing Ag85B-IFN-γ enhances the cell-mediated immunity in C57BL/6 mice
- (2017) Wei Liu et al. Experimental and Therapeutic Medicine
- Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
- (2017) José Mordoh et al. Frontiers in Immunology
- Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function
- (2017) Ricardo D. Lardone et al. Frontiers in Immunology
- The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
- (2017) Natalie E. Nieuwenhuizen et al. Frontiers in Immunology
- Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin
- (2017) Junbao Yang et al. Frontiers in Oncology
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BCG Vaccination Induces Robust CD4+T Cell Responses toMycobacterium tuberculosisComplex–Specific Lipopeptides in Guinea Pigs
- (2016) Eva Kaufmann et al. JOURNAL OF IMMUNOLOGY
- Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
- (2016) F Stephen Hodi et al. LANCET ONCOLOGY
- Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells
- (2016) R. Velmurugan et al. MOLECULAR CANCER THERAPEUTICS
- Developments in Intralesional Therapy for Metastatic Melanoma
- (2016) Sarah Sloot et al. Cancer Control
- Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
- (2016) Michal Lotem et al. Journal of Immunology Research
- Nonmuscle invasive bladder cancer: a primer on immunotherapy
- (2016) Mahir Maruf et al. Cancer Biology & Medicine
- Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma
- (2016) Anthony J. Olszanski JOURNAL OF MANAGED CARE PHARMACY
- Inflammasomes-dependent regulation of IL-1β secretion induced by the virulent Mycobacterium bovis Beijing strain in THP-1 macrophages
- (2015) Yang Zhou et al. ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY
- Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer
- (2015) K. R. Begnini et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKCα signaling: A potential candidate in melanoma cancer therapy
- (2015) Kuntal Halder et al. CANCER BIOLOGY & THERAPY
- Treatment of In-Transit Melanoma With Intralesional Bacillus Calmette-Guérin (BCG) and Topical Imiquimod 5% Cream
- (2015) Nour Kibbi et al. JOURNAL OF IMMUNOTHERAPY
- Efficacy and Safety of MCNA in Patients with Nonmuscle Invasive Bladder Cancer at High Risk for Recurrence and Progression after Failed Treatment with bacillus Calmette-Guérin
- (2015) Alvaro Morales et al. JOURNAL OF UROLOGY
- Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis
- (2015) Jinping Liang et al. MOLECULAR IMMUNOLOGY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Molecular drivers of cellular metabolic reprogramming in melanoma
- (2015) Cecilie Abildgaard et al. TRENDS IN MOLECULAR MEDICINE
- Inoculation Site from a Cutaneous Melanoma Patient Treated with an Allogeneic Therapeutic Vaccine: A Case Report
- (2015) Mariana Aris et al. Frontiers in Immunology
- Pathways and therapeutic targets in melanoma
- (2015) Emma Shtivelman et al. Oncotarget
- The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
- (2014) Boris C. Bastian Annual Review of Pathology-Mechanisms of Disease
- Major therapeutic developments and current challenges in advanced melanoma
- (2014) R.J. Sullivan et al. BRITISH JOURNAL OF DERMATOLOGY
- Melanoma immunotherapy
- (2014) Martina Sanlorenzo et al. CANCER BIOLOGY & THERAPY
- BCG-induced trained immunity in NK cells: Role for non-specific protection to infection
- (2014) Johanneke Kleinnijenhuis et al. CLINICAL IMMUNOLOGY
- New agents for bacillus Calmette–Guérin-refractory nonmuscle invasive bladder cancer
- (2014) Jennifer J. Ahn et al. CURRENT OPINION IN UROLOGY
- The Recombinant BCG ΔureC::hlyVaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation
- (2014) Hiroyuki Saiga et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects
- (2014) K. G. Griewank et al. JNCI-Journal of the National Cancer Institute
- MUC1 and maltose-binding protein recombinant fusion protein combined with Bacillus Calmette-Guerin induces MUC1-specific and nonspecific anti-tumor immunity in mice
- (2014) FANG FANG et al. Molecular Medicine Reports
- CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
- (2014) H.-J. Kim et al. Cancer Immunology Research
- Recombinant BCG: innovations on an old vaccine. Scope of BCG strains and strategies to improve long-lasting memory
- (2014) Adeliane Castro da Costa et al. Frontiers in Immunology
- Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape
- (2014) David McDermott et al. Cancer Management and Research
- Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells
- (2013) G. Redelman-Sidi et al. CANCER RESEARCH
- Melanoma epidemiology, biology and prognosis
- (2013) Z. Ali et al. EJC SUPPLEMENTS
- Melanoma’s connections to the tumour microenvironment
- (2013) Johanna M. Brandner et al. PATHOLOGY
- Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice
- (2013) Rosamund Chapman et al. PLoS One
- Long-term survival and outcome of patients originally givenMycobacterium vaccaefor metastatic malignant melanoma
- (2013) Ferdinando CM Cananzi et al. Human Vaccines & Immunotherapeutics
- Auxotrophic recombinant Mycobacterium bovis BCG overexpressing Ag85B enhances cytotoxicity on superficial bladder cancer cells in vitro
- (2012) Karine Rech Begnini et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Therapy for metastatic melanoma: the past, present, and future
- (2012) Laura Finn et al. BMC Medicine
- Adjuvant Therapy for Melanoma
- (2012) Diwakar Davar et al. CANCER JOURNAL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma
- (2012) A.C. Bougnoux et al. CLINICAL BIOCHEMISTRY
- Combined Intralesional Bacille Calmette-Guérin (BCG) and Topical Imiquimod for In-transit Melanoma
- (2012) Travis B. Kidner et al. JOURNAL OF IMMUNOTHERAPY
- Connaught and Russian Strains Showed the Highest Direct Antitumor Effects of Different Bacillus Calmette-Guérin Substrains
- (2012) Silvia Secanella-Fandos et al. JOURNAL OF UROLOGY
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Emerging molecular targets in melanoma invasion and metastasis
- (2012) Jose L. Orgaz et al. Pigment Cell & Melanoma Research
- Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials
- (2012) Christine M. Lovly et al. PLoS One
- The complex architecture of mycobacterial promoters
- (2012) Mae Newton-Foot et al. TUBERCULOSIS
- Vemurafenib (PLX4032): An Orally Available Inhibitor of Mutated BRAF for the Treatment of Metastatic Melanoma
- (2011) Yasser Heakal et al. ANNALS OF PHARMACOTHERAPY
- New Challenges in Endpoints for Drug Development in Advanced Melanoma
- (2011) A. Ribas et al. CLINICAL CANCER RESEARCH
- Role of bacillus Calmette–Guérin in the treatment of advanced melanoma
- (2011) John H Stewart et al. Expert Review of Anticancer Therapy
- Re-inventing intratumoral immunotherapy for melanoma
- (2011) Pierre L Triozzi et al. Immunotherapy
- Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma
- (2011) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses
- (2011) Christiane Desel et al. JOURNAL OF INFECTIOUS DISEASES
- Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing
- (2011) Mitchell S Stark et al. NATURE GENETICS
- Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
- (2011) Sergey I Nikolaev et al. NATURE GENETICS
- Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
- (2011) C. Garbe et al. ONCOLOGIST
- RAF protein-serine/threonine kinases: Structure and regulation
- (2010) Robert Roskoski BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- BRAF, a target in melanoma
- (2010) Keith T. Flaherty et al. CANCER
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity
- (2010) Alberto Mantovani et al. CURRENT OPINION IN IMMUNOLOGY
- MUC1-based recombinant Bacillus Calmette–Guerin vaccines as candidates for breast cancer immunotherapy
- (2010) Shifang Yuan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- BCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacy
- (2010) Jun Liu et al. Human vaccines & immunotherapeutics
- A phase 2 study of high-dose allovectin-7 in patients with advanced metastatic melanoma
- (2010) Agop Y. Bedikian et al. MELANOMA RESEARCH
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy of distant metastatic disease
- (2009) D. Schadendorf et al. ANNALS OF ONCOLOGY
- Comparable studies of immunostimulating activitiesin vitroamongMycobacterium bovisbacillus Calmette-Guérin (BCG) substrains
- (2009) Daisuke Hayashi et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Bacillus Calmette–Guerin immunotherapy for urothelial carcinoma of the bladder
- (2009) Timothy P Kresowik et al. Immunotherapy
- Serum Amyloid A As a Prognostic Marker in Melanoma Identified by Proteomic Profiling
- (2009) Peter Findeisen et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Recombinant Mycobacterium bovis BCG
- (2009) Reginaldo G. Bastos et al. VACCINE
- Complex cytokine profiles induced by BCG vaccination in UK infants
- (2009) Maeve K. Lalor et al. VACCINE
- Novel genome polymorphisms in BCG vaccine strains and impact on efficacy
- (2008) Andrea S Leung et al. BMC GENOMICS
- Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
- (2008) Rafael Carretero et al. IMMUNOGENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search